152 related articles for article (PubMed ID: 30522964)
1. Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Pharmacol Sci; 2019 Jan; 139(1):46-49. PubMed ID: 30522964
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
J Gastroenterol Hepatol; 2019 Jan; 34(1):186-193. PubMed ID: 29966173
[TBL] [Abstract][Full Text] [Related]
3. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Neurogastroenterol Motil; 2020 Jun; 32(6):e13819. PubMed ID: 32056324
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.
Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
Eur J Pharmacol; 2018 Jan; 818():228-234. PubMed ID: 29107672
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
[TBL] [Abstract][Full Text] [Related]
6. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
[TBL] [Abstract][Full Text] [Related]
7. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976
[TBL] [Abstract][Full Text] [Related]
8. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
[TBL] [Abstract][Full Text] [Related]
9. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
[TBL] [Abstract][Full Text] [Related]
10. EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Ishioh M; Takakusaki K; Okumura T
J Pharmacol Sci; 2021 Jul; 146(3):121-124. PubMed ID: 34030794
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.
Paragomi P; Rahimian R; Kazemi MH; Gharedaghi MH; Khalifeh-Soltani A; Azary S; Javidan AN; Moradi K; Sakuma S; Dehpour AR
Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):118-26. PubMed ID: 24471407
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats.
Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
J Gastroenterol Hepatol; 2018 Jan; 33(1):232-239. PubMed ID: 28440889
[TBL] [Abstract][Full Text] [Related]
13. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability.
Zang KH; Shao YY; Zuo X; Rao Z; Qin HY
J Med Food; 2016 Jun; 19(6):586-92. PubMed ID: 27111743
[TBL] [Abstract][Full Text] [Related]
14. Grape Seed Extract Eliminates Visceral Allodynia and Colonic Hyperpermeability Induced by Repeated Water Avoidance Stress in Rats.
Arie H; Nozu T; Miyagishi S; Ida M; Izumo T; Shibata H
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689935
[TBL] [Abstract][Full Text] [Related]
15. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
[TBL] [Abstract][Full Text] [Related]
16. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
[TBL] [Abstract][Full Text] [Related]
17. Multispecies probiotic protects gut barrier function in experimental models.
Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
[TBL] [Abstract][Full Text] [Related]
18. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
[TBL] [Abstract][Full Text] [Related]
19. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Neuropeptides; 2022 Aug; 94():102248. PubMed ID: 35526468
[TBL] [Abstract][Full Text] [Related]
20. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
